Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion wasGeneratedBy ECO_0000203 NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion wasDerivedFrom befree-2016 NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion SIO_000772 25511139 NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion evidence source_evidence_literature NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion description "[Therefore, in patients with CLL/SLL and rapidly enlarging asymmetric lymphadenopathy and/or extranodal tumors, we strongly advise FCM of fine-needle aspiration biopsy (FNAB) material, including CD62L, CD52, and CD71 analysis as well as assessment of karyotype and at least MYC abnormalities by FISH of the same FNAB material.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.